High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Nadia Arang, Simone Lubrano, Michele Ceribelli, Damiano C. Rigiracciolo, Robert Saddawi-Konefka, Farhoud Faraji, Sydney I. Ramirez, Daehwan Kim, Frances A. Tosto, Erica Stevenson, Yuan Zhou, Zhiyong Wang, Julius Bogomolovas, Alfredo A. Molinolo, Danielle L. Swaney, Nevan J. Krogan, Jing Yang, Silvia Coma, Jonathan A. Pachter, Andrew E. AplinDario R. Alessi, Craig J. Thomas, J. Silvio Gutkind (Lead / Corresponding author)
Dive into the research topics of 'High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma'. Together they form a unique fingerprint.